GLORIA is an international investigator – initiated trial aiming to prove (or disprove) that the addition of chronic low dose glucocorticoids to current anti-rheumatic therapy is cost-effective and safe, in elderly patients with Rheumatoid Arthritis (RA). About 50% of patients are currently treated with this strategy.
GLORIA is funded by the EU Horizon 2020 Program. >>
Jun 28, 2019 - Recent Publications \ News from GLORIA
A recent article with the title "Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial" has been recently published on the Scandinavian Journal of Rheumatology and we are proud to provide you with the PDF file. Just click here to view or download.
There are new patient folders available! You can acess them in the patient section here or by clicking directly below.
They are available in the following languages: Dutch, German, Hungarian, Romanian and Italian.
This is a paper recently published by some members of GLORIA team. The GLORIA project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634886.
It is possible to download the PDF document of this paper by clicking in the following link:
(Arthritis Care & Research DOI) 10.1002/acr.23185.